Consecución de objetivos farmacocinéticos/farmacodinámicos en pacientes críticos con monitorización terapéutica de linezolid
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
BACKGROUND: Standard dosing of linezolid regimen frequently results in suboptimal exposure in critically ill patients. This study aimed to analyze the association between dosing regimens (total daily dose and infusion duration) and the probability of achieving pharmacokinetic/pharmacodynamic targets, as well as their microbiological and clinical impact. METHODS: A retrospective observational study was conducted in critically ill patients admitted to intensive care units who underwent therapeutic drug monitoring of linezolid between May 2021 and December 2023. Achievement of pharmacokinetic/pharmacodynamic targets (Cmin: 2-7 mg/L, AUC: 0-24/MIC: 80-120 mg*h/L, and T>MIC =85%) was evaluated according to the initial regimens (1,200 or 1,800 mg/day) and infusion duration (1 or 3 hours). Risk subgroups included obesity, augmented creatinine clearance, renal replacement therapy, and age
Fields of Study & Subjects
Antibiotics Pharmacokinetics and Efficacy
Sepsis Diagnosis and Treatment
Neutropenia and Cancer Infections
Publication details
- Journal / source
- Anales del Sistema Sanitario de Navarra
- Volume
- 49
- Issue
- 1
- Pages
- e1151–e1151
- Publication date
- 31 March 2026
- Language
- ES